| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |